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THE IMPACT OF PARENTAL AND CHILD COPING STRATEGIES ON 
DISEASE OUTCOMES AND EMOTIONAL WELL-BEING IN CHILDREN 
WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASE 
JENNIFER K. WILSON 
ABSTRACT  
 
Background:  Inflammatory Bowel Disease (IBD), including Crohn’s disease (CD) and 
ulcerative colitis (UC), are chronic inflammatory conditions of the bowel that display a 
rising prevalence in childhood and adolescence. The diagnosis of a chronic condition, 
such as IBD, in childhood can be overwhelming and stressful for both the patient and 
caregiver. Parents and family members can play a critical role in providing emotional 
support for children with newly diagnosed IBD. We hypothesized that dysfunctional 
patient and parental coping strategies would correlate with increased anxiety and 
depression in children, worsening clinical disease activity, and increased healthcare 
utilization. 
Objective:  The primary objective of the IBD Coping Study is to assess the stability of 
coping strategies and psychological stress over the first year following a new diagnosis of 
IBD. Secondarily, we aim to assess the impact of child and parental coping strategies on 
disease activity and emotional well-being over the year.  
Methods:  This is a prospective, longitudinal cohort study of children with newly 
diagnosed IBD and their parents at Boston Children’s Hospital (BCH). Patients between 
the ages of 9 and 17 years old that have been diagnosed with CD, UC or Indeterminate 
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colitis (IC) within the last 6 months, are English-speaking, and receive routine care at 
BCH are approached for participation in our study. Participation includes the completion 
of previously validated psychological metrics for both child and parent at baseline and 
then again 12 months later. Our instruments include the Children’s Depression Inventory 
(CDI), the Screen for Child Anxiety Related Disorders (SCARED), the IMPACT-III 
Questionnaire, the Patient Health Questionnaire (PHQ-9), Healthcare Utilization Survey, 
Pediatric Inventory for Parents (PIP), and the Hospital Anxiety and Depression Scale 
(HADS).  
Results:  We screened 187 patients with IBD for participation in our study, and roughly 
30% of them were eligible for recruitment. To date, we have enrolled a total of 30 
patients. Of these patients, there was an equal distribution of male and female 
participants. The majority of patients were around 14 years of age at the time of IBD 
diagnosis with a greater number of patients with CD (17) currently represented. We are 
approaching patients on average about 1.5 months after their initial diagnosis. The 
baseline average Pediatric Ulcerative Colitis Activity Index (PUCAI) score was 21.15 ± 
20.53, whereas the average Pediatric Crohn’s Disease Activity Index (PCDAI) score was 
3.75 ± 2.50. On CDI items, teenage girls and boys reported increased raw and 
standardized scores (Raw: 5.83 and 4.83, respectively; Standardized: 43.67 and 44.67, 
respectively) than their younger counterparts for depressive behaviors, including negative 
mood and interpersonal problems. Pediatric patients encountered as inpatients reported an 
overall lower quality of life on IMPACT-III items (103.29 ± 15.11) than those 
approached in the ambulatory setting (140.36 ± 7.50). On SCARED items, patients met 
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criteria for the potential presence of one or more anxiety disorders. Inpatients also 
reported being bothered more frequently with respect to hindrances in their sleep, 
appetite, and daily routines on the PHQ-9 metric. Parents of children with newly 
diagnosed IBD rely on increased communication with their child’s primary GI provider, 
and their scores reflected lower emotional functioning during an admission period when 
compared to scores reported during regular scheduled ambulatory visits. Scores collected 
from the HADS screen demonstrate that 6% and 33% of parents reported a score great 
enough to be considered a “borderline case” for depression and anxiety measures, 
respectively. Primary comparisons between child health assessments and parent 
healthcare utilization depicted concurrent elevations in the same child-parent pair at 
baseline.  
Conclusion:  Our initial findings suggest a clear disparity between emotional stability in 
children and their parents in outpatient and inpatient settings following a new IBD 
diagnosis. Healthcare utilization by parents may be linked to adaptive or maladaptive 
coping, and continuation of our study will substantiate this prediction. In looking ahead, 
potential interventions may require approaches stratified by age, gender, and hospital 
setting. Our study supports the need for further investigations into the impact of targeted 
interventions that promote an improvement in overall quality of life in children with IBD 
and their family during the first year of post-diagnosis.  
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INTRODUCTION 
 
Inflammatory Bowel Disease Prevalence and Clinical Presentation 
Roughly 1 million individuals in the United States and 2.5 million in Europe 
suffer from Inflammatory Bowel Disease (IBD) (Kaplan, 2015). Increasing cases of IBD, 
with as many as 70,000 new cases identified in the United States each year are especially 
prominent in Caucasian and Ashkenazi Jewish populations (Crohn's & Colitis 
Foundation, 2014; Hanauer, 2006). With the prevalence rate of this chronic condition 
steadily rising, particularly in young children and adolescents, it is important to gain a 
better understanding of the interplay between emotional and psychosocial states and 
clinical and biological outcomes.  
Inflammatory bowel disease, including Crohn’s disease (CD) and ulcerative 
colitis (UC) can present with a number of clinical symptoms, including crampy 
abdominal pain, bloody diarrhea, fever, lethargy, delayed growth and puberty, as well as 
extraintestinal manifestations in eyes, bone, and skin (Bishop, Lemberg, & Day, 2014; 
Higuchi & Bousvaros, 2017; “Inflammatory bowel disease (IBD) Symptoms”, n.d.)  
Crohn’s disease (CD) can occur in any part of the gastrointestinal tract from the 
oral cavity to the anus, and commonly involves the small intestine. The inflammation 
observed in patients with CD can be patchy in its distribution and often spares the rectum. 
The inflammation is often transmural, extending through the entire intestinal wall lining 
(CCF, 2014). Conversely, the inflammation observed in patients with ulcerative colitis is 
restricted to the mucosal lining of the colon. A diagnosis of indeterminate colitis is made 
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when the clinical, histologic, and radiologic appearance of the disease displays features 
consistent with both CD and UC.  
 
Inflammatory Bowel Disease Treatments and Psychological Impact 
The initial treatment for children with IBD is established based on a myriad of 
factors, including the severity of disease activity, diagnostic imaging, and laboratory 
results. The use of pediatric ulcerative colitis and pediatric Crohn’s disease activity 
indices (PUCAI and PCDAI, respectively) enables providers to gauge a patient’s disease 
severity using previously validated scoring metrics. Utilizing this information, 
appropriate treatments are recommended and revised based on the child’s clinical 
response or lack of response. 
Clinicians caring for children with IBD will often employ agents that either 
induce and/or maintain disease remission. Corticosteroids, including prednisone and 
prednisolone can induce disease remission. However, these treatments are not 
recommended for long-term therapy due to side effects (Colombel et al., 2010). 
Cytokines released during inflammation can lead to changes in activity in brain regions 
that influence emotional regulation in depression (Jones et al., 2011), and this can be 
compounded in the context of corticosteroid use (Graff, Walker, & Bernstein, 2009). 
Anti-TNF therapies, such as Infliximab or Adalimumab, are used to induce and maintain 
clinical and endoscopic remission in patients with moderate to severe CD and UC 
(Colombel et al., 2010), and require visits to a hospital infusion center, or the self-
administration of painful injections (Buisson, Seigne, D’huart, Bigard, & Peyrin-Biroulet, 
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2013). Unlike orally administered classes of IBD medications, including aminosalicylates 
or immunomodulators, the use of biologic agents may require a child to miss school or 
extracurricular and athletic activities, both of which can necessitate the need for 
additional adaptations and social/emotional stressors on a child and their family.   
  
IBD Diagnosis in Children  
Approximately 20% of patients with IBD are diagnosed prior to age 20, and there 
is a slightly higher incidence rate noted for CD (CCF, 2014). Existing data demonstrates 
that children with IBD often present with earlier and more complicated disease courses 
than their adult counterparts (Higuchi & Bousvaros, 2017). This heightened disease 
severity can also result in patients and their families feeling overwhelmed at the time of 
diagnosis. 
 
Patient and Familial Physical and Emotional Burden  
Children and their families must accommodate the testing requisite to fully assess 
for IBD. This typically requires scheduling bloodwork, endoscopic and colonoscopic 
evaluations, as well as small bowel imaging with abdominal MRI, CT, or fluoroscopic 
exams. Further, because symptoms of IBD can flare up unexpectedly, increases in disease 
activity often result in missed days of school, activities and hobbies, and, worse, can 
require hospitalization. The nature of a patient’s physical symptoms can be embarrassing 
and difficult to discuss with peers. The missed days of work and accompanying 
healthcare costs can create financial stress and put extra strain on a couple’s relationship.  
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 The psychosocial burden of an IBD diagnosis is likely to be disproportionate 
during that first year, as this can be associated with the biggest changes in the patient’s 
body, side effects from medications, frequent visits to the doctor, and potential declines 
in self-esteem (Bishop et al., 2014; Lindfred, Saalman, Nilsson, & Reichenberg, 2008). 
For a parent, seeing their child in pain can be difficult enough, let alone the challenge of 
dealing with an abrupt lifestyle change confused by new medical jargon, and, in some 
cases, parents may require more psychological adjustment than their ill child (MacPhee, 
Hoffenberg, & Feranchak, 1998).  
According to data published in the Inflammatory Bowel Diseases Journal, anxiety 
and depression are more common in patients with IBD when compared to patient 
populations without a chronic condition. Anxiety and depression in pediatric patients may 
be exacerbated by poor stress management, as well as dysfunctional parental coping 
mechanisms, and thus contribute to an overall decline in health-related quality of life 
(HRQOL) (McCombie, Mulder, Gearry, 2015). Coping can be subspecialized into 
various dimensions that target particular emotional or problem-solving domains. 
Adaptive emotion-focused coping is typically characterized by strategies such as 
“distancing, humor, and seeking social support.” In contrast, strategies that are generally 
considered maladaptive include “escape-avoidance, day dreaming, and blaming” 
(Folkman, 2013). Problem-based coping centers on “information gathering, seeking 
advice, drawing on previous experience, negotiating, and problem solving” (Folkman, 
2013). While these definitions are accurate and beneficial in targeting therapeutic 
approaches, coping mechanisms are highly idiosyncratic across individual patients, and 
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they are often complicated by a specific person’s support network and feelings of self-
worth and confidence. Children and adolescents are just beginning to shape their identity 
as they encounter new life experiences, and they may not understand or know the 
appropriate approach for them following a new medical diagnosis (Bishop et al., 2014). 
Thus, they will often model their parents’ behavior, which may or may not be 
maladaptive, and this can be a predictor of depression over time. Coping mechanisms and 
parental stress have been explored further in children with diabetes and heart disease. 
Specifically, in the Diabetes Educator Journal, researchers investigated the level of 
psychological stress in parents of children with type 1 diabetes and how it related to 
health outcome. It was found that parental psychological distress “was associated with 
higher child self-report of stress and depressive symptoms, more problematic child 
behavior, and lower child self-report of quality of life…also had negative effects on 
diabetes management (Whittemore, Jaser, Chao, Jang, & Grey, 2012). Screening for 
depression and facilitating the development of adaptive coping strategies and 
preventative interventions for parents and children with a chronic illness is therefore 
vitally important.  
Maladjustment to a child’s illness can result in a parent’s efforts to distance 
themselves from the patient and their own pain and fear, and this will ultimately 
irrevocably affect the development of the child-parent relationship (Ljubica et al., 2013). 
An example is found in the parental response to children with congenital heart disease. In 
Pediatric Cardiology, researchers formulated a systematic review of “parenting 
practices” for appropriate interventions to enhance family coping. Ultimately, they found 
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that early psychosocial intervention could be effective in the development of productive 
parenting practices (Jackson, Frydenberg, Liang, Higgins, & Murphy, 2015). It is 
conceived that poor stress management in parents can directly impact a child’s disease 
course over time, perhaps leading to increased medical usage and hospitalizations, and 
negatively impact the relationship with one’s child (MacPhee et al., 1998). 
 Previous data has demonstrated that maladaptive coping strategies can contribute 
to suboptimal disease outcomes and impaired parent-child attachment. In this study, we 
will further assess the impact of parental stress and coping on IBD specifically. The 
introductory data presented in this work is one of many preliminary steps aimed at 
identifying the patients and families most in need of social and cognitive support. 
Interventions may range from frequent phone or in-person “check-ins” to therapy 
sessions to improve stress management, and ultimately, reduce medical utilization and 
improve disease outcomes in children with newly diagnosed IBD. 
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SPECIFIC AIMS 
  
The principle aims of our study are the following: 
 
• Assess the stability of stress and coping parameters over time in parents and 
children following a new IBD diagnosis.  
 
• Assess the impact of parental coping on disease activity in their children with 
newly diagnosed IBD.  
 
• Assess the impact of parental coping on depression, anxiety, and quality of life in 
children with newly diagnosed IBD. 
 
• Assess the impact of parental coping on healthcare resource utilization in children 
with newly diagnosed IBD. 
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MATERIALS AND METHODS 
 
Study Design  
We are currently performing a prospective, longitudinal cohort study of children 
with newly diagnosed IBD and their parents at Boston Children’s Hospital. We are 
enrolling children, ages 9-17, and their parents within 6 months of initial diagnosis of 
IBD. We plan to follow-up with this cohort 12 months after enrollment. A diagnosis date 
is defined as date of the initial endoscopic evaluation.  
 
Participant Selection 
Patient selection is determined primarily through the use of hospital electronic 
medical records, beginning on January 1, 2017 and extending through March 26, 2018. 
The research team reviews GI Pathology reports, IBD ambulatory and medication 
infusion visit records, daily IBD inpatient list, and GI provider referrals at BCH and BCH 
satellite locations, to identify children with newly diagnosed IBD. Additionally, eligible 
patients must receive their longitudinal IBD care at BCH and have had no changes made 
to their psychotropic medications in the last 6 months.  
 
Study Measures  
For children, we collect measures of health-related quality of life, anxiety and 
depression through established questionnaires presented in the following order at baseline 
and again 12 months later. 
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1. The Children’s Depression Inventory (CDI; Kovacs, 1979) is a universal self-
report tool that assesses symptoms of depression in children and adolescents. It 
consists of 27 items that are rated on a three-point scale (0-2) with respect to 
feelings and ideas experienced within the past two weeks (Figure 1). The items 
are grouped into five dimensions:  “Negative Mood”, “Interpersonal Problems”, 
“Ineffectiveness”, “Anhedonia” (inability to feel pleasure) and “Negative Self-
Esteem” (Kovacs, 1992). Raw scores can range from 0-54, which are converted to 
standardized T-scores based on gender and age. Statistical reliability and validity 
have been established (Saylor et al., 1984). 
 
2. Screen for Child Anxiety Related Emotional Disorders (SCARED, child 
version; Birmaher et al., 1999) is a self-report questionnaire used to assess 
anxiety disorders in children and adolescents. It consists of 41 items that are rated 
on a three-point scale (0-2) with respect to feelings experienced within the last 
three months (Figure 2). This assessment is based on the Diagnostic and 
Statistical Manual of Mental Disorders (DSM), including generalized anxiety, 
separation anxiety, social anxiety, panic disorder or significant somatic 
symptoms, and significant school avoidance. A score of 25 or greater may 
indicate the presence of an anxiety disorder, and a score greater than 30 may be 
more specific for one or more of the types mentioned. 
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3. The IMPACT-III Questionnaire (Otley et al., 2002, 2006) is a self-report health-
related quality of life (HRQOL) survey for children with IBD. It consists of 35 
questions grouped in the following domains:  “Body Image”, “Treatments and 
Interventions”, “Bowel Symptoms”, “Social Functioning”, “Emotional 
Functioning”, and “Systemic Symptoms” (Figure 3). The composite range for 
IMPACT-III is 0-238, in which the higher the score, the better quality of life 
(Otley et al., 2006). Statistical reliability, specifically test-retest reliability and 
validity are strongly evident (Otley et al., 2002). 
 
4. The Patient Health Questionnaire (PHQ-9; Kroenke, 2011) is a self-report tool 
to assess for and monitor the severity of depression in primary care settings 
(Figure 4). It consists of 9 questions that present problems experienced in the last 
two weeks, indicated by 0 (“Not at all”), 1 (“Several days”), 2 (“More than half 
the days”) and 3 (“Nearly every day”). Question 9 screens for any indication of 
suicide ideation, and, if so, the duration of this feeling. If indicated for any patient 
enrolled in our study, we immediately alert their primary gastroenterologist of the 
response, and are equipped with a staff psychologist for consultation if needed. 
Scores range from 0-27, and equal to or greater than 10 indicates the likelihood of 
depression. Validity was ascertained in research incorporating primary care and 
obstetric clinics (Kroenke, Spitzer, & Williams, 2001). 
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Figure 1. Children’s Depression Inventory (CDI) (taken from Kovacs, 1979) 
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Figure 1. Continued 
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Figure 2. Screen for Child Anxiety Related Disorders (SCARED) (taken from 
Birmaher et al., 1999) 
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Figure 2. Continued 
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Figure 3. The IMPACT-III Questionnaire (taken from Otley et al., 2002, 2006) 
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Figure 3. Continued  
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Figure 3. Continued   
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Figure 3. Continued  
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Figure 3. Continued  
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Figure 3. Continued   
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Figure 3. Continued  
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Figure 4. Patient Health Questionnaire-9 (PHQ-9) (taken from Kroenke, 2011) 
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For parents, we collect measures of coping, anxiety, and depression through 
established questionnaires presented in the following order. These are completed by 
either the patient’s mother, father, or legal guardian at baseline and again 12 months later. 
 
1. The Healthcare Utilization Survey is a 6-item assessment to determine common 
parental and family actions with respect to their child’s IBD treatment and disease 
maintenance within the last month. Items address pediatric doctor’s visits, GI 
doctor’s visits, trips to the Emergency Room, and hospitalizations. The items are 
open-ended to prompt a numerical or non-applicable response (Figure 5). 
 
2. The Pediatric Inventory for Parents (PIP; Streisand, Braniecki, Tercyak, & 
Kazak, 2001) is a tool to measure stress in parents of children who have a serious 
illness, including a chronic condition like IBD (Figure 6). It consists of 42 items 
on a 5-point scale (1-5) to determine the frequency and difficulty of stressful 
experiences, such as trouble sleeping, being unable to work, and worrying about 
their child’s illness and well-being. Scoring is determined on the aforementioned 
rating scale for 4 unique domains – “Communication”, “Emotional Distress”, 
“Medical Care”, and “Role Function”. The range of scores is 42-210 with 
caregiver stress expected to be higher for worsening child disease severity. 
Excellent reliability and validity were determined in pediatric IBD in recent years 
(Gray, Graef, Schuman, Janicke, & Hommel, 2013). 
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3. The Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 
1983) is an assessment established to detect anxiety and depression in outpatient 
and inpatient medical settings within the past week. It is comprised of 14 items on 
a 4-point scale (0-3) for both depression and anxiety subscales (7 items for each 
subscale). Scores 0-7 indicate “normal” whereas 8-10 indicate “borderline case”, 
and 11-21 indicate “abnormal case” (Figure 7). This valid and reliable measure 
can be administered any number of times to assess emotional stability in parents 
(Snaith, 2003). 
 
 
Figure 5. Healthcare Utilization Survey (taken from Zimmerman, 2017) 
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Figure 6. Pediatric Inventory for Parents (PIP) (taken from Streisand et al., 2001) 
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Figure 6. Continued  
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Figure 7. Hospital Anxiety and Depression Scale (HADS) (taken from Zigmond and 
Snaith, 1983) 
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Data Collection  
Children determined eligible for participation were recruited in the GI 
ambulatory, medical infusion, and inpatient settings. Eligible patients were approached 
only after their primary provider deemed it was an appropriate time to be involved in our 
research. Patients and their parents were given all questionnaires (displayed above), and 
they were told that they were welcome to skip any questions that made them 
uncomfortable or stop the test entirely at any time. If a question was determined as 
uncomfortable, the patient was reminded to indicate they did not want to complete that 
particular item by either putting an “X” or “Not Applicable” next to the question for 
accurate coding purposes. For those patients that elected to use the electronic versions, 
there was an option to select “I choose not to answer”. Along with the self-reported 
responses, the study team obtained baseline and follow-up medical data. Baseline 
measures include pertinent demographic information, date of IBD diagnosis, disease 
activity PUCAI and PCDAI records, clinical phenotype and disease extent/severity, 
relevant biomarkers (i.e. ESR, CRP, HCT, FLA), and current IBD medications. At the 
patient’s follow-up visit, the study team will obtain lab results, such as the ones listed 
above and PUCAI or PCDAI measures. Moreover, number of phone calls to providers, 
clinic or ER visits, hospitalizations, IBD “flares”, and major abdominal surgeries will 
also be analyzed. Number of phone calls are ascertained by reviewing the BCH GI 
overnight call logs. For this study, IBD “flares” are defined by a change in clinical 
circumstances that trigger the addition of a new medication, escalation in the dose of an 
existing mediation, or scheduling investigative endoscopic and/or radiographic imaging.   
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All study data was obtained from electronic medical records on the internal BCH 
network, and stored in Microsoft Excel and Word formats in a password-protected 
hospital drive. Completed paper questionnaires were safely stored in the Principle 
Investigator’s locked office. All enrolled patient information will be transferred to the 
Research Electronic Data Capture (REDCap), a secure web database utilized for research 
within BCH. Any online responses inputted via the custom survey link will be 
automatically stored in REDCap for data analysis. Each patient was assigned a unique 
study identification number (i.e. BCOPE001) that was attached to all relevant medical 
information and survey responses to protect participant privacy. This electronic database 
creates a Case Report Form (CRF) to aggregate participant data and facilitate analysis 
and interpretation of results. The CRF subsections include demographic information 
(Figure 8), all 7 survey responses, and disease outcome measures at follow-up (Figure 9). 
Not all survey CRFs will be complete due to participant decision to skip certain questions 
that make them uncomfortable, time constraints, and loss to follow-up, which refers to 
when a participant is unreachable or declines to complete both stages of our study.  
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Figure 8. IBD Coping Demographics Case Report Form (CRF) from REDCap. 
Relevant baseline demographic information collected on all enrolled patients if available. 
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Figure 8. Continued   
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Figure 9. IBD Coping Outcome Measures Case Report Form (CRF) from REDCap. 
Follow-up data to be collected on all enrolled patients if available. 
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Figure 9. Continued  
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RESULTS 
 
Patient Population 
To date, we have identified 187 IBD patients, of which 61 were eligible and 126 
were ineligible determined by the criteria mentioned. There are 30 enrolled patients, 
comprised of 15 females and 15 males with either CD or UC. Of the 30 enrolled, one 
female participant has been withdrawn due to turning age 18 before date of consent, 
therefore making her ineligible to complete the follow-up stage. The first four follow-up 
patients were approached in-person or contacted via email between January and March 
2018. To date, receipt of survey completion from most of the follow-up patients is still 
pending. Tables 1 to 3 further describe the characteristics of our enrolled patient 
population.  
We plan on enrolling 50-70 IBD patients and families. This study was approved 
by the Institutional Review Board (IRB) at Boston Children’s Hospital (Protocol 
Number: P00023915) with Continuing Review approved on October 25, 2017, extending 
study activity to October 24, 2018. 
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*F/U = Follow-up 
Figure 10. Boston Children’s Hospital IBD Coping Study Flow Diagram. Figure 
demonstrates patient selection components as defined by the inclusion and exclusion 
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criteria from January 1, 2017 to March 26, 2018. Eligibility review is comprised of total 
enrolled (baseline, baseline and follow-up, withdrawn, and loss to follow-up), pending 
updates, and declines. Greater than one exclusion criteria may include >6-month new 
diagnosis date and >17 years old or <9 years old and non-English speaking. Withdrawn 
participant due to age 18 at time of consent. 
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Table 1. Enrolled patient population at baseline 
Characteristic  Classification 
Outcome 
(%) 
Patient diagnosis  IBD  30 
   CD  17 (56.67) 
   UC  13 (43.33) 
   IC  Null (N/A) 
Gender   Male  15 (50) 
   Female  15 (50) 
   Male CD  8 (53.33) 
   Male UC  7 (46.67) 
   Male IC  Null (N/A) 
   Female CD  9 (60) 
   Female UC  6 (40) 
   Female IC  Null (N/A) 
Age in years   Mean*  14.23 
(Date of dx** - DOB***)  Range*  8.99-17.92 
   Male Max  17.90 
   Male Min  8.99 
   Male Mean  14.47 
   Female Max* 17.92 
   Female Min* 10.96 
   Female Mean* 13.99 
Length of diagnosis in days Mean*  43.34 
(Consent date - date of dx**) Range*  2-178 
   Male Max  178 
   Male Min  2 
   Male Mean  52.40 
   Female Max* 173 
   Female Min* 2 
   Female Mean* 34.29 
*Excludes characteristics form one withdrawn female participant due to age 
**dx = Diagnosis  
***DOB = Date of Birth  
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Table 2. Enrolled patient population at 12 month follow-up  
Characteristic  Classification 
Outcome 
(%) 
Total enrolled  IBD  30 
Baseline only complete  CD  16 (53.33) 
   UC  13 (43.33) 
   IC  Null (N/A) 
Baseline and follow-up complete CD  1 (3.33) 
   UC  Null (N/A) 
   IC  Null (N/A) 
Loss to follow-up  IBD  TBD 
   CD  TBD 
   UC  TBD 
   IC  Null (N/A) 
Distribution in days  Mean  362.25 
(Between baseline and follow-up 
dates) Range  354-368 
   Male Mean  363.50 
   Female Mean 361 
*TBD = To Be Determined (near the time of overall study completion)  
 
Table 3. Enrolled patient population PUCAI and PCDAI levels at baseline  
Activity Index Mean Activity Level 
   
PUCAI  21.15 ± 20.53 
   
PUCAI – Inpatient  28.57 ± 23.75 
   
PUCAI – Ambulatory  12.50 ± 12.94 
   
PCDAI  3.75 ± 2.50 
   
PCDAI – Inpatient  5.00 ± 0 
   
PCDAI – Ambulatory  3.33 ± 2.87 
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*Baseline mean PCDAI level for enrolled inpatients is somewhat inconclusive at this 
time. Of the 6 Crohn’s disease patients, out of 17 approached during admission, almost 
all but one had no composite PCDAI or component scores recorded at time of admission 
or surrounding clinic visits for IBD work-up. In one case, a PUCAI score was reported 
for a patient subsequently diagnosed with Crohn’s disease. 
 
In Table 1, it is important to note that of 30 enrolled patients, there were just 
slightly over half CD patients at 17 (56.67%) and 13 (43.33%) UC patients with no IC 
patients yet enrolled. Gender was equally represented with 15 female and 15 male 
participants thus far. Patients were around 14 years of age when diagnosed with IBD, and 
at the time of enrollment, the average number of days since their initial endoscopic IBD 
finding was roughly 43 days. The range was 2 days to 178 days, and all patients 
consented 2 days post endoscopy were diagnosed while admitted to the hospital for said 
IBD work-up. 
Figure 10 depicts that of the patients enrolled, 16 patients were approached at an 
ambulatory appointment, 12 during an inpatient hospital stay, in which a recent diagnosis 
may have occurred during that particular stay, and 1 invited via a custom digital survey 
invitation. Ambulatory patients were either scheduled to see a provider or present to 
complete an infusion in the Center for Ambulatory Treatment and Clinical Research 
(CAT/CR) or Boston Children’s at Waltham Infusion Center.  
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In Table 2, the first four follow-up patients were approached in-person or 
contacted via email between January and March 2018. The mean distribution of days 
between baseline and follow-up was around 364 and 361 for male and female 
participants, respectively. Contact for enrolled follow-up visits and online participation 
will take place in 2018 to 2019.   
In Table 3, the baseline average ambulatory Pediatric Ulcerative Colitis Activity 
Index (PUCAI) score was 12.50 ± 12.94 with an overall range of 0-85 where 0 indicates 
no severity and 85 indicates high disease severity. PUCAI calculates disease severity on 
the basis of abdominal pain, rectal bleeding, stool consistency, number of stools in 24 
hours, nocturnal awakening of stool urgency, and activity level. At baseline, the mean 
inpatient PUCAI score was 28.57  23.75. Furthermore, at baseline, the mean ambulatory 
short Pediatric Crohn’s Disease Activity Score (PCDAI) score was 3.33  2.87, whereas 
the short PCDAI score for inpatients was inconclusive with only one score available (5). 
Many CD patients enrolled were approached during ambulatory appointments. The range 
is 0-100 where 0-10 indicates inactive disease, 10-30 mild disease and >30 moderate to 
severe disease. According to CCF, PCDAI is based on abdominal pain, daily stools, 
weight, growth, presence of perianal disease or extraintestinal manifestations, and 
laboratory studies.  
 
Baseline Child Depression and Anxiety Measures 
 Data is categorized into those collected in ambulatory and inpatient cohorts as 
well as individual psychometric measures outlined in the study questionnaires. 
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The Children’s Depression Inventory at Baseline 
 The information collected in the Children’s Depression Inventory (CDI) assesses 
for feelings related to self-worth and self-esteem, factors that may indicate the presence 
of depression in children and adolescents. Raw scores are determined by summing the 
numeric values (0-2) for each item response with a higher score indicating a more defined 
depressed behavior or manifestation. Standardized T-scores have a mean of 50 and a 
standard deviation of 1 x 101, which reflects a typical or atypical child based on age and 
sex (Kovacs & Multi-Health Systems Staff, 2011). High T-scores indicate a high level of 
depressive symptoms, such as lack of pleasure and negative mood and self-esteem.  
 
Table 4. Standardized CDI T-Score Interpretation (adapted from Kovacs and Multi-
Health Systems Staff, 2011)  
T-Score T-Score Interpretation  
< 40 
Below Average Score  
(Fewer concerns than are typically reported) 
40 – 49 
Average Score  
(Typical number of concerns) 
50 – 59 
Slightly Above Average Score  
(Slightly more concerns than are typically 
reported) 
60 – 64  
High Average Score  
(Somewhat more concerns than are typically 
reported) 
65 – 69  
Elevated Score  
(More concerns than are typically reported) 
70 – 90+ 
Very Elevated Score  
(Many more concerns than are typically 
reported) 
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Figure 11. Baseline Children’s Depression Inventory – Mean Raw Score by Hospital 
Setting. Mean response rate across 27 items in outpatient and inpatient settings.   
 
 
Figure 12. Baseline Children’s Depression Inventory – Mean Standardized T-Score 
by Hospital Setting. Reflects the standardized mean response rates, which were 
converted from original raw scores based on age and gender in two clinical settings. 
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The mean response rate for items in the CDI recorded from ambulatory and 
inpatient participants was 3.77 and 5.86, respectively. Following conversion of average 
raw scores to standardized T-Scores, the mean response rate for ambulatory and inpatient 
participants was 41.23 and 45.86, respectively. According to Table 3, the mean 
participant response rate expresses a normal number of concerns, and is considered 
“average”.   
 
 
Figure 13. Baseline Children’s Depression Inventory – Mean Raw Score by Gender 
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Figure 14. Baseline Children’s Depression Inventory – Mean Standardized T-Score 
by Gender. Reflects the standardized mean response rates, which were converted from 
original raw scores based on age and gender. 
 
The mean response raw score is further categorized by gender and age 
parameters. Responses from boys in the 7-12 and 13-17 year-old age cohorts reveal 
composite scores of 4.00 and 4.83, respectively. Additionally, boys in the younger and 
older cohorts reflect an average standardized score at 40.67 and 44.67, respectively. Girls 
age 7-12 years old reported the lowest raw score (2.80), whereas the corresponding 
standardized score of 41.00 is slightly above their young male peers. Girls age 13-17 
years old reported the highest mean total score (5.83) as compared to the second highest 
standardized score (43.67). 
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Figure 15. Baseline Children’s Depression Inventory – Female Mean Standardized 
T-Score. Reflects the standardized female mean response rate by instrument domain. 
 
 
Figure 16. Baseline Children’s Depression Inventory – Male Mean Standardized T-
Score. Reflects the standardized male response rate by instrument domain.  
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Mean standardized scores collected from females in the study depict some 
variability from typical child behaviors. Negative mood, interpersonal problems, 
ineffectiveness, and anhedonia all fell into the “average” range (42.75 to 44.81). 
However, negative self-esteem appeared to raise fewer concerns than average. Similarly, 
anhedonia, interpersonal problems, and negative mood domains were all considered 
average for male participants, and negative self-esteem raised the fewest concerns for 
boys (41.22) and girls (39.25) of all ages than did other domains. 
 
The Screen for Child Anxiety Related Disorders at Baseline 
 The Screen for Child Anxiety Related Disorders (SCARED) is an instrument used 
to identify subjects along dimensions of anxiety, namely, panic or somatic, separation, 
generalized, and school phobia. The mean ambulatory and inpatient raw totals were 13 
and 19.6, respectively. Scores ranged from 0 to 50 in ambulatory settings, and 4 to 38 in 
hospitalized patients. The instrument suggests that any raw score of 25 or higher raises 
suspicion for the presence of an anxiety disorder, and scores higher than 30 are specific 
for one or more of the subgroups listed. 10 patients reported very low raw scores that did 
not qualify for any anxiety disorder. The remaining participants met criteria for at least 
one or more types of anxiety. The most common were separation anxiety and significant 
school avoidance. 
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*N/A = Not Applicable 
Figure 17. Baseline SCARED Anxiety Outcomes. The percentage of enrolled 
participants that reported a score equal to or greater than 25 across all instrument items to 
suggest the presence of one or more anxiety disorders. “N/A” indicates the percentage of 
participants that reported a score less than 25, which does not meet the requirements for 
an anxiety disorder.  
 
The IMPACT-III Questionnaire for Inflammatory Bowel Disease at Baseline 
Data collected in the IMPACT-III quality of life questionnaire addresses the 
impact of IBD symptoms and how they impact on emotional and social well-being. The 
mean total score for enrolled participants was 125.94 ± 24.63, specifically 140.36 ± 7.50 
for outpatients and 103.29 ± 15.11 for inpatients. The highest score attainable is 238, 
indicating a superior quality of life. The individual domains indicate higher mean values 
and positive quality of life outcomes for patients in the ambulatory setting when 
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compared to hospitalized patients, across all domains, in particular for emotional and 
social functioning. 
Table 5. Baseline IMPACT-III Mean Scores by Domain 
Domain  Mean Score 
   
Bowel Symptoms 23.67 ± 6.66 
   
Treatments and Interventions 11.17 ± 3.42 
   
Emotional Functioning 25.11 ± 6.08 
   
Systemic Symptoms 10.00 ± 3.43 
   
Body Image  11.00 ± 2.74 
   
Social Functioning 45.00 ± 8.51 
   
Total Score  125.94 ± 24.63 
 
Table 6. Baseline IMPACT-III Mean Scores in Ambulatory Patients  
Domain  Mean Score 
   
Bowel Symptoms 26.91 ± 5.20 
   
Treatments and Interventions 11.91 ± 3.59 
   
Emotional Functioning 28.82 ± 4.49 
   
Systemic Symptoms 11.64 ± 2.50 
   
Body Image  11.55 ± 2.46 
   
Social Functioning 49.55 ± 6.15 
   
 Total Score  140.36 ± 7.50 
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Table 7. Baseline IMPACT-III Mean Scores in Admitted Patients 
Domain  Mean Score 
   
Bowel Symptoms 18.57 ± 5.56 
   
Treatments and Interventions 10.00 ± 3.00 
   
Emotional Functioning 19.29 ± 2.50 
   
Systemic Symptoms 7.43 ± 3.21 
   
Body Image  10.14 ± 3.13 
   
Social Functioning 37.8 6± 6.69 
   
Total Score  103.29 ± 15.11 
 
 
The Patient Health Questionnaire at Baseline 
Data collected in the Patient Health Questionnaire (PHQ) assess the presence and 
frequency of events, including lack of interest or pleasure, fatigue, and difficulty 
concentrating. The mean ambulatory and inpatient response rate was 3.45 and 6.00, 
respectively. The total number of questions is 9 with a score ranging from 0-27. Most 
patients indicated that an event did not bother them at all, represented by a zero, whereas 
less than 5% of patients indicated a particular event bothered them nearly every day. The 
most common events indicated by patients as bothersome were “feeling tired or having 
little energy” and “poor appetite or overeating”.  All candidates thus far have indicated 
coping with any event occurring as being “not at all difficult” to “somewhat difficult”. 
One instance of a positive suicide ideation score was found in an inpatient, which was 
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handled immediately by directly notifying the Principle Investigator and the GI inpatient 
attending physician who took the next appropriate steps to ensure the patient’s safety.   
 
 
Figure 18. Baseline Patient Health Questionnaire. The mean response rate of each 
event ranging in frequency from 0-3 with “0=Not at all”, “1=Several days”, “2=More 
than half the days”, and “3=Nearly every day”.  
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Figure 19. Baseline Patient Health Questionnaire – Mean Composite Raw Score by 
Hospital Setting. Mean raw score of all events. 
 
Baseline Parent Depression and Anxiety Measures 
Preliminary data for parental emotional stability focuses on manifestation of 
anxiety and depressive behaviors and healthcare utilization as an indicator or poor coping 
strategies during the first year of their child’s IBD diagnosis. 
 
The Healthcare Utilization Survey at Baseline 
 The Healthcare Utilization Survey is a self-report assessment of the number of 
clinic visits, phone contact, and admissions to the hospital within the past month. Mean 
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were not as evident with the mean under 1 instance at 0.7 and 0.35, respectively.  Figure 
21 identifies the percentage of parents engaged in low (≤0-2), moderate (3-5), and high 
(6-12+) healthcare utilization instances, which may be a predictor of negative or positive 
coping mechanisms.   
 
 
*ER = Emergency Room 
Figure 20. Baseline Mean Healthcare Utilization by Parent. The frequency of 
healthcare utilization by parents in attending to their child’s IBD diagnosis. 
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Figure 21. Baseline Percentage of Parents Engaged in Hospital Utilization. Number 
of individual healthcare instances, such as a phone call or clinic visit is defined as ≤0-2 = 
“low”, 3-5 = moderate, and 6-12+ = high.  
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Figure 21. Continued   
 
 
Figure 21. Continued   
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Figure 21. Continued   
 
 
Figure 21. Continued 
 
The Pediatric Inventory for Parents at Baseline 
 The Pediatric Inventory for Parents (PIP) reviews the frequency and difficulty of 
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75%
20%
5%
0%
Baseline Number of Phone Calls to GI Doctor
≤0-2 3-5 6-10 10-12+
0% indicates no 
response recorded
in the 10-12+ 
range (Red)
100%
0%
Baseline Number of Inpatient Hospitalizations
≤0-2 3-5+
0% indicates no 
response recorded
in the 3-5+ range 
(Orange)
  56 
frequency and difficulty is associated with a higher rating on a Likert scale (ranging from 
5 to 1) for each item. Across all events, parents of inpatients reported higher frequency 
and difficulty measures than parents of outpatients. Most notably, parents reported high 
frequency (Ambulatory: 32.67; Inpatient: 54.00) and difficulty (Ambulatory: 35.08; 
Inpatient: 50.00) of events in emotional functioning or distress, such as worrying about 
their child’s needs and the needs of other family members. Conversely, parents reported 
fewer difficult instances of communication with healthcare staff and family about their 
child’s illness. The p-values for frequency and difficulty are 0.17 and 0.58, respectively. 
 
 
*p > 0.05 (p = 0.17) 
Figure 22. Baseline Pediatric Inventory for Parents – Frequency. The average sum of 
event frequency (1-5) by instrument domain. Each item provides the options:  “1=Never”, 
“2=Rarely”, “3=Sometimes”, “4=Often”, and “5=Very often”.  
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*p > 0.05 (p = 0.58) 
 
Figure 23. Baseline Pediatric Inventory for Parents – Difficulty. The average sum of 
each event difficulty, which can range from 1-5 for an allotted maximum of 210. Each 
item on the questionnaire provides the following options:  “1=Not at all”, “2=A little”, 
“3=Somewhat”, “4=Very much”, and “5=Extremely”.  
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outpatients was 6.4 and 3.4, respectively.  The p-values for depression (0.21) and anxiety 
(0.15) are not yet significant.  
 
 
*p > 0.05 for mean depression score (p = 0.21) 
**p > 0.05 for mean anxiety score (p = 0.15) 
Figure 24. Baseline Hospital Anxiety and Depression Scale – Mean Total Score. 
Presence and magnitude of parental anxiety and depression. Each item is rated on a three-
point scale, in which 0 and 3 indicate opposite extremes. The higher the raw score, the 
higher probability of anxiety or depression symptoms. 
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Figure 25. Baseline Hospital Depression Classification. The percentage of parent 
participants that reported a score that fits normal, borderline, and abnormal cases of 
depression.  
 
 
Figure 26. Baseline Hospital Anxiety Classification. The percentage of enrolled parent 
participants that reported a score that fits normal, borderline, and abnormal cases of 
anxiety.   
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Comparison Between Child and Parent Reported Behaviors  
 
 
*Number of participants only includes half of the current enrolled population, which does 
not have any missing or pending instrument values (n = 15). 
Figure 27. Comparison Between Total Patient Health Questionnaire and Parent 
Utilization Scores. Reflects preliminary linear trends (dashed lines) of PHQ to 
Healthcare Utilization outcomes.  
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*Number of participants only includes just over half of the current enrolled population, 
which does not have any missing or pending instrument values (n=17). 
Figure 28. Comparison Between Screen for Child Anxiety Related Disorders and 
Parent Hospital Anxiety Scores. Reflects preliminary linear trends (dashed lines) of 
SCARED to Hospital Anxiety Scale. 
 
A comparison of early outcomes in total scores of child PHQ9 and parent 
healthcare utilization, as well as child SCARED and parent HADS, should allow further 
assessment of the complex psychosocial relationship between child-parent pairs in our 
study and how this relates to healthcare utilization and clinical outcome.  
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DISCUSSION 
 
The primary purpose of this study is to assess the stability of coping strategies and 
emotional distress of children and their parents over the first year following a new 
diagnosis of IBD. Our study is well underway, and 30 patient/parent dyads have 
completed the first encounter questionnaires. We will follow-up with all enrolled patients 
at one year from the date of their initial recruitment for the final survey administration. 
Due to loss to follow-up and withdrawn participants, we will seek to approach at least 50 
more patients to complete our recruitment goal.  
 There are a variety of approaches to assess psychological behavior in children 
with chronic illness. In our study, we chose to focus on manifestations of anxiety and 
depression, as the impact of these challenges on parental stress and coping in pediatric 
IBD has not been fully investigated. We further chose to include measures that captured 
specific life stressors in caring for a child with newly diagnosed IBD, including the 
frequency of medical appointments, involvement in medical procedures, and the impact 
of seeing one’s child in pain. (Gray et al., 2013). Additionally, the patient instruments 
focus particularly on how anxiety and depression impact on bowel symptoms, questions 
about treatment and medications, and how they feel around friends and classmates.  
 We have three main hypotheses in our study. The first is that children with newly 
diagnosed IBD that come from families that display maladaptive coping strategies will 
demonstrate more anxiety and depressive behaviors. The second is that poor parental 
coping will lead to increased disease activity and/or worse clinical improvement in 
children over time. The third is that poor parental coping will correlate to increased 
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healthcare utilization. As this is a prospective, longitudinal study, we will continue to 
evaluate our hypotheses as we accrue patients and their families, especially in the follow-
up stage. Additionally, some data points are pending, and therefore preliminary trends do 
not yet fully encompass the enrolled population. However, all inclinations are important 
in assessing child and parent needs and potential interventions in the context of a new 
IBD diagnosis.  
 The data that we collected using the Children’s Depression Inventory 
demonstrates that depressive symptoms, including low self-esteem and negative mood, 
are more prevalent in inpatients than outpatients. Both the mean raw and standardized T-
scores demonstrate a greater response rate to negative items (i.e. “I do everything 
wrong.”) than to neutral or positive items (i.e. “I do most things O.K.”). Higher raw and 
T-scores indicated more defined depressive symptoms (Kovacs & Multi-Health Systems 
Staff, 2011). One study found that depression in hospitalized children manifested in more 
headaches and abdominal pain as well as was positively influenced by higher parental 
depression as compared to non-hospitalized children (Kashani, Barbero, & Bolander, 
1981). The CDI trend thus far supports psychological and social intervention, especially 
in hospitalized patients as well as the correlation between parental stress and child 
disease outcome.  
 The CDI data collected in this study also demonstrates that teenage girls are more 
likely to report negative responses than their younger female and male counterparts. T-
scores below 49 are considered “average or lower than average”, whereas a score higher 
than 59 is considered “elevated” or “very elevated” above 70. All T-scores calculated for 
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the current population were between 39 and 44, and 41 and 44 for female and male 
participants, respectively. Higher T-scores, indicating that depressive symptoms are more 
prominent with respect to “ineffectiveness” in girls and roughly equal for “negative 
mood” and “interpersonal problems” in boys. Ineffectiveness encompasses items related 
to pleasure, motivation in child’s schoolwork, and comparison to other kids. Negative 
mood is defined by items related to feelings of sadness, worrisome thoughts, and 
difficulty making up one’s mind. Interpersonal problems are comprised of items relating 
to self-perceptions, following the rules, and interactions with other people. These 
introductory findings highlight the importance developing targeted interventions and 
support based on age and gender at time of diagnosis. 
 The Screen for Anxiety and Related Disorders assesses anxiety symptoms in 
children with newly diagnosed IBD. One study from the 2012 Canadian Community 
Health Survey on Mental Health concluded that individuals with IBD displayed more 
than twice the likelihood of anxiety as compared to those without IBD (Fuller-Thomson, 
Lateef, & Sulman, 2015). In general, raw scores that are greater than or equal to 25 may 
indicate the presence of an anxiety disorder with a score of 30 specific for one or more 
types of anxiety. As shown in Figure 17, roughly 32% of the enrolled population had raw 
scores that were less than 25 and did not meet the criteria mentioned above, indicated by 
“N/A”. However, the remaining participants reported scores that may indicate the 
presence of one or more anxiety disorders. These are only screening values, and are not 
clinical diagnoses, but include separation anxiety, panic disorder, social anxiety, 
generalized anxiety, and significant school avoidance. Patients that reached the threshold 
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for one of these subtypes had a score between 3 and 9 for specific anxiety (Figure 2). The 
majority of participants met the requirement for separation anxiety and significant school 
avoidance. Previous literature says that anxiety may arise in children due to separation 
from parents or family (Bsiri-Moghaddam, Basiri-Moghaddam, Sadeghmoghaddam, & 
Ahmadi, 2011). Understandably, this could arise in our target cohort of school-age 
children who live at home with parents or guardians. It will be important to assess the 
follow-up responses one year later for a decline in anxiety outcomes, perhaps when 
patients and their parents have had the opportunity to become more familiar and 
comfortable with their diagnosis. 
The IMPACT-III Questionnaire, a quality of life measure specific for IBD 
features 6 different domains. The instrument aggregates individual items to yield a score 
for each domain as well as an overall total score. Items range from 1-5 in varying 
responses with a higher total score indicating a better quality of life. The maximum total 
score is 175, which reflects a superior quality of life. The maximum score for bowel 
symptoms and emotional functioning items is 35 for each domain, whereas the maximum 
score for treatments and interventions, systemic symptoms, and body image items is 15 
for each domain. The maximum score for social functioning is 60. Table 5 shows the 
mean score and standard deviation for each domain across enrolled participants thus far. 
Items that were left blank due to patient preference at time of survey administration were 
omitted from the calculated scores. Patients appeared to have a relatively good quality of 
life with a mean total score of 125.94. However, the broad standard deviation (24.63) 
demonstrates the presence of individuals who fall in the extremes of either superior or 
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less optimal quality of life. Most notably, social functioning and bowel symptoms have 
the greatest standard deviations, apart from the overall total, which may be reported 
differently based on child maturity and school environment. Examples of social 
functioning items include “Despite your IBD can you take part in as much sport as you 
would like?” and “Is it harder to make friends because of IBD?”. Examples of bowel 
symptoms include “How much are you afraid you may have an accident?” and “How 
often did you feel sick in the last two weeks?” (Figure 3).  
 Tables 6 and 7 divide our patient population into inpatient and outpatient settings. 
We hypothesized that hospitalized patients are overall more likely to report a lower 
quality of life score across some or most of the domains due to negative emotions 
associated with not being well enough to attend to one’s symptoms at home or the need 
for further assessment.  In a study performed in similarly-aged pediatric oncology 
patients, hospitalization can lead to physical, emotional and social trauma that are 
triggered by fear, treatments, and the unknown (Obaid, 2015). Additionally, changes in 
one’s daily routine are likely alarming for the patient. This can lead to a regressive 
behavior, a coping mechanism that is often observed in hospitalized patients (Obaid, 
2015). In particular, newly diagnosed inpatients enrolled in our study, the initial 
endoscopic evaluation for IBD may leave them especially vulnerable to anxiety due to 
the unknown relating to the procedure and underlying findings. 
 Preliminary data does show that for each domain and total score, the mean score 
for inpatients was lower, indicating a poorer quality of life, when compared to data 
collected in ambulatory patients. Studies have shown that a general decline in positive 
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emotions and increase in anxiety occur in the inpatient setting. Of particular note, 
admitted patients showed greater discrepancies on bowel symptoms and emotional and 
social functioning with corresponding mean total scores of 18.57 ± 5.56, 19.29 ± 2.50, 
and 37.86 ± 6.69, respectively, than for body image or medical treatments. The trends 
suggest that overall quality of life in children newly diagnosed with IBD experience more 
negative emotions related to changes in their bodies, relationship to others, and self-
perceptions. We will learn more about child perceptions at their one year follow-up. 
Therefore, this data can propagate the discussion for increased attention toward the 
physical symptoms and how patients identify following a new diagnosis.  
 The Patient Health Questionnaire is a tool to identify frequency related to feeling 
down or depressed, fatigue, and suicide ideation. For any problems marked 0-2 in 
increasing frequency, patients are asked to describe how difficult these are on a scale of 
“not difficult at all” to “extremely difficult”. In general, the majority of patients selected 
“not at all” for each item, which is scored as a 0, and not of major concern. Moreover, the 
mean response rate declined as event frequency increased. It can be hypothesized that 
patients admitted to the hospital would be in a less positive state and mark events more 
frequently as depicted in Figure 18. Similarly, those patients who are hospitalized might 
have a higher overall mean score than outpatients. However, studies have shown that 
anxiety and depression are common in general in IBD patients (Goodhand et al., 2012).  
Ambulatory IBD outpatients can also suffer from anxiety and/or depression. This can 
amplify disease severity (Byrne et al., 2017), and underscore the need for the 
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development and application of more rigorous screening regimens by physicians during 
scheduled office visits. 
 Data presented in Figure 20, demonstrates that parents engage more in phone calls 
with their pediatrician and primary GI doctor than visits to clinic or the Emergency Room 
when seeking guidance for the care of their children with IBD. Roughly 85% of patients 
spend up to two clinic visits with their child’s pediatrician and GI doctor around the time 
of their diagnosis. 10% of parents reported taking their child to the ER for an IBD-related 
concern. Moreover, parents reported spending time on the phone with their child’s 
pediatrician or GI doctor a maximum of 10 different occasions. This does not include 
length of contact or email messaging, in which the parent might also engage.  
 We did not see a correlation between parent’s Healthcare Utilization responses 
and their child’s Patient Health Questionnaire responses (Figure 27). However, there 
were a few instances (n = 3, 7, 9, and 15) in which higher PHQ scores (an elevated score 
indicates presence of emotional distress symptoms in children) were correlated with an 
elevated sum of parent resource utilization. Further input when additional survey 
responses are obtained might show a clearer trend (or an entirely new tendency), all of 
which are important in evaluating the needs for children with IBD and their parents. 
 The Pediatric Inventory for Parents is a widely used instrument to capture 
parenting stress associated with caring for an individual with a pediatric illness (Gray et 
al., 2013). Scoring is divided along four dimensions – role function, emotional 
functioning, medical care, and communication based on frequency and level of difficulty 
of the events that comprise the scales mentioned. The range of scores is 42-210 with 
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caregiver stress expected to be higher for more disease severity. Data shown in Figure 22 
demonstrates that frequency of events was greater for inpatients than outpatients at 140 
and 89, respectively. Similarly, inpatient scores were slightly to moderately higher than 
ambulatory patient scores, which was potentially due to a more stressful environment, 
particularly as it relates to medical care and communication with physicians and nurses. 
Emotional functioning was the highest individual score for both outpatients and 
inpatients. This domain encompasses seeing one’s child sad or isolated, worrying about 
the long-term impact of the illness, feeling helpless, among other items. The p-score was 
greater than 0.05 (0.17), which is non-significant, but we expect will change as patient 
data is obtained and incorporated with the existing results. 
 Figure 23 shows the difficulty of those events. While the p-score for this metric is 
also non-significant (0.58), it is important to note that higher levels of difficulty were 
reported for events related to emotional distress and role function. Role function 
encompasses role conflict and strain with family members as well as placing all of the 
attention on the ill child. In addition, findings for both frequency and difficulty were 
elevated for data collected in the inpatient setting. This trend is supported in the literature, 
particularly with respect to caregivers of adolescents with IBD experiencing low rates of 
parenting stress during outpatient care and phases of disease inactivity (Guilfoyle, 
Denson, Baldassano, & Hommel, 2012).  
 The Hospital Anxiety and Depression Scale screens for anxiety and depression in 
parents. Average levels of anxiety and depression across study participants were higher 
for parents of inpatients than outpatients. The p-scores were 0.21 and 0.15 for depression 
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and anxiety, respectively. The score ranges from 0-21 with 0-7 considered “normal case”, 
8-10 considered “borderline case”, and 11-21 considered “abnormal case”. The 
percentage of parents was greatest in the normal range (83% and 56% for depression and 
anxiety, respectively). In contrast, there was a much greater percentage of parents in the 
borderline range (33%) with respect to anxiety, as compared to the depression borderline 
case (6%). The same percentage (11%) of parents met criteria for both anxiety and 
depression. The highest depression score recorded was 19, whereas the highest anxiety 
score reported was 21 out of 21 for each.   
 Data presented in Figure 28 compares the child’s responses to SCARED and the 
corresponding parent’s responses to HADS. Similar to Figure 27, the outcomes may 
fluctuate as we input more data; however, it is important to highlight some instances 
where the child score was elevated, and the HADS total for anxiety was also raised (n = 2 
and 12).  
 The importance of identifying families most in need of psychosocial support and 
interventions is the primary focus of our efforts. Other research has shown that anxiety 
and depression are common in patients with IBD and healthcare professionals should be 
advised to observe for these manifestations (Byrne et al., 2017; Fuller-Thomson et al., 
2015; Goodhand et al., 2012). The preliminary results from our prospective study 
demonstrate the need for additional supports for families managing an IBD diagnosis in 
the context of the initial hospital setting.  
 There are some limitations to this study. Most notably, self-reported 
psychological measures may lead to larger than anticipated gaps in the data due to 
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missing or pending instrument measures, patient selection bias, and/or error. Other 
disadvantages may include child and parent responses that are exaggerated or 
conservative due to embarrassment or social desirability. Additionally, the duration 
between first encounter and follow-up of 12 months could increase the percentage of loss 
to follow-up or withdrawn participants. This period might not be a long enough time 
interval to see a difference in those patients and families who complete both stages. 
Missing data from medical records, especially disease activity levels and lab values may 
hinder the full analysis of our hypotheses. Lastly, this study aims to benefit children with 
IBD and their parents, therefore it would be advantageous to expand and incorporate 
multiple centers to observe the broader trends outside of BCH. This would not only 
bolster recruitment numbers, but gain a better sense of the psychosocial needs of this 
vulnerable patient population.  
In spite of the weaknesses, our study has been generally accepted by families and 
GI colleagues at BCH. The project has gained momentum since its inception, and can 
now be administered in person and online, which will further enhance our recruitment 
initiative. Overall, the results will provide physicians and healthcare staff a more in-depth 
understanding of patient well-being, parental coping tendencies, and psychosocial needs 
in the year following a new IBD diagnosis.  
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CONCLUSION 
 
 
 
The primary aim of this study is to assess the stability of coping strategies and 
psychological distress of children and their parents over the first year following a new 
diagnosis of IBD. The secondary aim is to examine if parental coping correlates with 
improved disease activity in the child, less healthcare utilization, and better quality of life 
in the child. 
Our study is still underway and therefore, disease outcome measures determined 
in the year between initial encounter and follow-up have not yet been determined. 
However, preliminary data does suggest a higher prevalence rate of anxiety and 
depression symptoms in parents and their children in the inpatient versus outpatient 
setting. In addition, teenage girls and boys appeared to be the most susceptible to 
depression in this context when compared to their younger counterparts. Finally, there 
was an introductory correlation between high levels of healthcare utilization or poor 
parental coping, and increased anxiety and emotional distress in their children. 
 At this time, the study is ongoing until an appropriate number of enrolled patients 
is reached. Currently, the study is led by Dr. Lori Zimmerman and Dr. Paul Rufo at 
Boston Children’s Hospital, but our hope moving forward will be to enroll and collect 
data from other local and regional IBD centers. The resulting broader dataset should 
broaden our population and demonstrate the generalizability of our findings.  
 Inflammatory Bowel Disease, and any chronic illness, can impact 
disproportionally on children, their caregivers, and siblings. Our study is a first effort to 
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stratifying patients and parents to identify those most at risk for psychosocial 
comorbidity. We hope to develop targeted resources that will support patients and their 
families during the initial stage of diagnosis and beyond. Ultimately, we hope that these 
and similar efforts by other investigators will enhance quality of care and reduce overall 
medical utilization in this patient population in the future. 
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